Live Breaking News & Updates on Life Science Virtual Symposium

Konica Minolta Precision Medicine to Present on the Future of Integrated Diagnostics at AWS Healthcare & Life Science Virtual Symposium
Tom Schoenherr, CEO of Ambry Genetics, Introduces the LATTICE™ Platform
News provided by
Share this article
Share this article
ALISO VIEJO, Calif., May 27, 2021 /PRNewswire/  Konica Minolta Precision Medicine (KMPM), announced today that Tom Schoenherr, Chief Executive Officer of Ambry Genetics, a KMPM company, will present at the third annual AWS Healthcare & Life Science Virtual Symposium on Thursday, May 27, 2021.
The presentation will introduce the LATTICE™ platform, a groundbreaking integrated diagnostic data platform combining genomics, pathology, radiology data, and other critical information to uncover new, clinically relevant biomarkers and create the next generation of diagnostic tests. LATTICE leverages machine learning services by combining KMPM s cutting-edge science with the added power of AWS to acceler ....

Tom Schoenherr , Liz Squire , Ambry Genetics Corporation , Konica Minolta Precision Medicine Inc , Konica Minolta Company , Konica Minolta Precision Medicine , Chief Executive Officer , Ambry Genetics , Life Science Virtual Symposium , Minolta Precision Medicine , Minolta Precision , டோம் ஸ்கொன்ஹெர் , லிஸ் ஸ்கைர் , கொநிக மினோல்டா ப்ரிஸிஶந் மருந்து இன்க் , கொநிக மினோல்டா நிறுவனம் , கொநிக மினோல்டா ப்ரிஸிஶந் மருந்து , தலைமை நிர்வாகி அதிகாரி , மினோல்டா ப்ரிஸிஶந் மருந்து ,